メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のオメガ3脂肪酸製品市場:タイプ、:用途、地域別

Global Omega-3 Product Market - Growth, Trends, and Forecast (2018 - 2023)

発行 Mordor Intelligence LLP 商品コード 572854
出版日 ページ情報 英文 110 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.89円で換算しております。
Back to Top
世界のオメガ3脂肪酸製品市場:タイプ、:用途、地域別 Global Omega-3 Product Market - Growth, Trends, and Forecast (2018 - 2023)
出版日: 2018年04月01日 ページ情報: 英文 110 Pages
概要

オメガ3脂肪酸製品市場は、主にエイコサペンタエン酸(EPA)とドコサヘキサエン酸(DHA)ベースの製品で構成されています。栄養サプリメント市場の成長や、開発途上国における乳児用調整粉乳向けの大きな需要が当市場の成長要因となっています。

当レポートでは、オメガ3脂肪酸の世界市場を調査し、市場の概要、タイプ・用途・濃度・地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 主な調査結果
  • 調査の前提条件
  • 市場の定義

第2章 調査方法

  • イントロダクション
  • 調査計画
  • 調査のタイムライン
  • 調査の段階
    • 2次調査
    • ディスカッションガイド
    • マーケットエンジニアリングと計量経済学モデリング

第3章 市場の概要

  • 市場動向
    • 成長要因
    • 阻害要因
    • 市場機会
    • ポーターのファイブフォース分析

第4章 市場セグメンテーション

  • タイプ別
    • エイコサペンタエン酸(EPA)
    • ドコサヘキサエン酸(DHA)
  • 濃度タイプ別
    • 高濃縮タイプ
    • 濃縮タイプ
    • 低濃縮タイプ
  • 用途別
    • 乳児用調整粉乳
    • 栄養強化食品・飲料
    • 臨床栄養・医薬品
    • ダイエットサプリメント
    • 医薬品
    • 動物栄養
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 南米
    • アフリカ

第5章 競合情勢

  • 主要企業の戦略
  • 過去5年間最も活発な企業
  • 市場シェア分析

第6章 企業プロファイル

  • DSM NUTRITIONAL PRODUCTS
  • BIOPROCESS ALGAE LLC
  • Cargill Incorporated (US)
  • SOURCE-OMEGA
  • QUALITAS HEALTH
  • NORDIC NATURALS
  • ADM
  • ALGAECYTES
  • SIMRIS ALG
  • Algisys
  • FMC Corporation (US)
  • TerraVia (Solazyme)
  • Croda International PLC (UK)
  • Nature's Way (Ascenta Health)

第7章 付録

  • 免責事項
  • 参考資料
目次
Product Code: 34870

Market Insights

The global omega-3 product market was valued at USD 31.4 billion in 2015. Omega-3 products consist of eicosapentanoic acid (EPA) and docosahexanoic acid (DHA) based products. The omega-3 ingredients market is growing faster than the omega-3 products market.

Growing Functional Food = Omega-3 Product Demand

The global omega-3 product market has been dominantly driven by the strong demand for infant formula products in developing regions such as China. Omega-3 demand is growing at a faster rate in infant food fortification as it provides the essential DHA for infant brain development. In addition, the global dietary supplement market is growing at a faster rate, which has increased the demand for omega-3 supplements. However, the major restraint for the market is the depleting fish population, which is the primary source of omega-3. The other marine sources of omega-3 are krill oil and algae oil. Algae-sourced omega-3 is the fastest growing market due to various factors. Omega-3 obtained from algae is considered more bioavailable and sustainable for production, which is a need of the hour because overfishing is a major problem. Another benefit associated with algae omega-3 is that it is best suited for vegetarians. Moreover, the product quality of algae omega-3 is superior as compared to fish oil because it is free from toxic pollutants, highly pure in terms of form of fatty acid, and its off sensory properties. Another major restraint for the market is the high cost of product due to higher downstream processing cost. However, due to technological advancements, its price is forecasted to reduce, making this market highly competitive.

Infant Formula Consumption Growing at a Faster Rate

The market has been segmented by type, concentration type, application type, and geography. There are commercially two types of essential omega-3 fatty acids - eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). DHA holds the largest share in the market due to its high demand in infant formula products and legal recommendations regarding it. EPA-based products are the fastest growing market, supported by the various health benefits, which have increased its importance in drug formulation. By concentration type, the market is segmented into high concentrated, concentrated, and low concentrated product. Currently, low concentrated and concentrated omega-3 products are capturing the market. Growing awareness among consumers regarding the daily dosage of omega-3 has increased the demand for high concentrated products. By application, the market is segmented into infant formula, dietary supplements, fortified food & beverages, clinical nutrition and medical foods, pharmaceuticals, and animal nutrition. The infant formula market is growing at a CAGR of 8.2% during the forecasted period. Animal nutrition is another major growing segment for the market due to increased health concerns among pet owners.

Regional Analysis

The global omega-3 product market has been segmented by region into North America, Europe, Asia-Pacific, South America, and Africa. Asia-Pacific is the fastest growing region due to the growing fortified food market and increased consumer awareness. Japan and China are the significant market in the Asia-Pacific region. Asia-Pacific holds the major share in the omega-3 products market due to high infant formula consumption, followed by North America with a market share of 32%. South America is another growing market for omega-3 fatty acid driven by the high consumption of fortified products.

Key Developments

January 2018 - DSM and Evonik have established a joint venture for omega-3 fatty acids from natural marine algae for animal nutrition.

June 2017 - FMC Corporation has signed a definitive agreement to sell its Epax Omega-3 business to Pelagia AS.

The major players include - DSM NUTRITIONAL PRODUCTS, BIOPROCESS ALGAE, LLC, CARGILL, INCORPORATED, SOURCE-OMEGA, QUALITAS HEALTH, NORDIC NATURALS, ADM, ALGAECYTES, SIMRIS ALG, ALGISYS, FMC CORPORATION, TERRAVIA (SOLAZYME), CRODA INTERNATIONAL PLC, NATURE'S WAY (ASCENTA HEALTH), amongst others.

Reasons to Purchase this Report

Analyzing outlook of the market with the recent trends and Porter's five forces analysis

Market dynamics which essentially consider the factors, which are impelling the present market scenario, along with growth opportunities of the market in the years to come

Market segmentation analysis, including qualitative and quantitative research incorporating the impact of economic and non-economic aspects

Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market

Competitive landscape involving the market share of major players, along with the key strategies adopted for development in the past five years

Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

3-month analyst support, along with the Market Estimate sheet in excel

Customization of the Report

This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs

Table of Contents

1. Introduction

  • 1.1 Key Deliverables of the study
  • 1.2 Study Assumptions
  • 1.3 Market Definitions

2. Research Approach and Methodology

  • 2.1 Introduction
  • 2.2 Research Design
  • 2.3 Study timelines
  • 2.4 Study Phases
    • 2.4.1 Secondary Research
    • 2.4.2 Discussion Guide
    • 2.4.3 Market Engineering & Econometric Modelling
    • 2.4.4 Expert Validation

3. Market Overview

  • 3.1 Market Dynamics
    • 3.1.1 Drivers
      • 3.1.1.1 Increased demand of infant forrmula products in developing region such as China
      • 3.1.1.2 Growing demand of sustainable source of Omega 3 fatty acid suitable for vegeterian label
      • 3.1.1.3 Increasing Demand for Omega-3 in Functional Foods & Pharmaceuticals
    • 3.1.2 Restraints
      • 3.1.2.1 Depleting fish oil concentration globally
      • 3.1.2.2 Higher downstream processing cost
    • 3.1.3 Opportunities
      • 3.1.3.1 Growing demand of algae EPA in drug application
    • 3.1.4 Porter's Five Forces Analysis
      • 3.1.4.1 Bargaining Power of Suppliers
      • 3.1.4.2 Bargaining Power of Buyers
      • 3.1.4.3 Threat of New Entrants
      • 3.1.4.4 Threat of Substitute Products and Services
      • 3.1.4.5 Degree of Competition

4. Market Segmentation

  • 4.1 By Type
    • 4.1.1 Eicosapentanoic acid (EPA)
    • 4.1.2 Docosahexanoic acid (DHA)
  • 4.2 By Concentration Type
    • 4.2.1 High Concentrated
    • 4.2.2 Concentrated
    • 4.2.3 Low Concentrated
  • 4.3 By Application
    • 4.3.1 Infant Formula
    • 4.3.2 Fortified food & Beverages
    • 4.3.3 Clinical nutrition and medical foods
    • 4.3.4 Dietary Supplement
    • 4.3.5 Pharmaceuticals
    • 4.3.6 Animal Nutrition
  • 4.4 By Geography
    • 4.4.1 North America
      • 4.4.1.1 United States
      • 4.4.1.2 Canada
      • 4.4.1.3 Mexico
      • 4.4.1.4 Others
    • 4.4.2 Europe
      • 4.4.2.1 Spain
      • 4.4.2.2 UK
      • 4.4.2.3 France
      • 4.4.2.4 Germany
      • 4.4.2.5 Russia
      • 4.4.2.6 Italy
      • 4.4.2.7 Others
    • 4.4.3 Asia Pacific
      • 4.4.3.1 China
      • 4.4.3.2 India
      • 4.4.3.3 Japan
      • 4.4.3.4 Australia
      • 4.4.3.5 Others
    • 4.4.4 South America
      • 4.4.4.1 Brazil
      • 4.4.4.2 Argentina
      • 4.4.4.3 Others
    • 4.4.5 Africa
      • 4.4.5.1 South Africa
      • 4.4.5.2 Others

5. Competitive Landscape

  • 5.1 Strategy adopted by Key players
  • 5.2 Most active companies in the past five years
  • 5.3 Market Share Analysis

6. Company Profiles

  • 6.1 DSM NUTRITIONAL PRODUCTS
  • 6.2 BIOPROCESS ALGAE, LLC
  • 6.3 Cargill, Incorporated (U.S.)
  • 6.4 SOURCE-OMEGA
  • 6.5 QUALITAS HEALTH
  • 6.6 NORDIC NATURALS
  • 6.7 ADM
  • 6.8 ALGAECYTES
  • 6.9 SIMRIS ALG
  • 6.10 Algisys
  • 6.11 FMC Corporation (U.S.)
  • 6.12 TerraVia (Solazyme)
  • 6.13 Croda International PLC (U.K.)
  • 6.14 Nature's Way (Ascenta Health)

7. Appendix

  • 7.1 Disclaimer
  • 7.2 Sources
Back to Top